These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 34662672)

  • 1. Tumor microenvironment-responsive dynamic inorganic nanoassemblies for cancer imaging and treatment.
    Yang Y; Wu H; Liu B; Liu Z
    Adv Drug Deliv Rev; 2021 Dec; 179():114004. PubMed ID: 34662672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimuli-responsive nanoassemblies for targeted delivery against tumor and its microenvironment.
    Sia CS; Lim HP; Tey BT; Goh BH; Low LE
    Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188779. PubMed ID: 35977690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-responsive dynamic nanoassemblies for targeted imaging, therapy and microenvironment manipulation.
    Low LE; Wu J; Lee J; Tey BT; Goh BH; Gao J; Li F; Ling D
    J Control Release; 2020 Aug; 324():69-103. PubMed ID: 32423874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Microenvironment Sensitive Nanocarriers for Bioimaging and Therapeutics.
    Park H; Saravanakumar G; Kim J; Lim J; Kim WJ
    Adv Healthc Mater; 2021 Mar; 10(5):e2000834. PubMed ID: 33073497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
    Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
    Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
    [No Abstract]   [Full Text] [Related]  

  • 6. Smart Nanoplatforms Responding to the Tumor Microenvironment for Precise Drug Delivery in Cancer Therapy.
    Wang Y; Deng T; Liu X; Fang X; Mo Y; Xie N; Nie G; Zhang B; Fan X
    Int J Nanomedicine; 2024; 19():6253-6277. PubMed ID: 38911497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox-manipulating nanocarriers for anticancer drug delivery: a systematic review.
    Meng X; Shen Y; Zhao H; Lu X; Wang Z; Zhao Y
    J Nanobiotechnology; 2024 Sep; 22(1):587. PubMed ID: 39342211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designing Stimuli-Responsive Upconversion Nanoparticles that Exploit the Tumor Microenvironment.
    Ovais M; Mukherjee S; Pramanik A; Das D; Mukherjee A; Raza A; Chen C
    Adv Mater; 2020 Jun; 32(22):e2000055. PubMed ID: 32227413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ROS-Responsive Nanomedicine: Towards Targeting the Breast Tumor Microenvironment.
    Malla RR; Kamal MA
    Curr Med Chem; 2021; 28(28):5674-5698. PubMed ID: 33297907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Charge-Reversal Nano-Drug Delivery Systems in the Tumor Microenvironment: Mechanisms, Challenges, and Therapeutic Applications.
    Liang Y; Wu J; Yan Y; Wang Y; Zhao H; Wang X; Chang S; Li S
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH-sensitive nano-systems for drug delivery in cancer therapy.
    Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
    Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoplatform-based cascade engineering for cancer therapy.
    Chen J; Zhu Y; Wu C; Shi J
    Chem Soc Rev; 2020 Dec; 49(24):9057-9094. PubMed ID: 33112326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Microenvironment Stimuli-Responsive Fluorescence Imaging and Synergistic Cancer Therapy by Carbon-Dot-Cu
    Sun S; Chen Q; Tang Z; Liu C; Li Z; Wu A; Lin H
    Angew Chem Int Ed Engl; 2020 Nov; 59(47):21041-21048. PubMed ID: 32914924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimuli-responsive Smart Liposomes in Cancer Targeting.
    Jain A; Jain SK
    Curr Drug Targets; 2018 Feb; 19(3):259-270. PubMed ID: 26853324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologically based strategies for overcoming in vivo barriers with functional nano-delivery systems.
    Ahmadzadeh R; Taheri SA; Mohammadi N; Hjazi A; Menon SV; Kadhum WR; Kumar A; Shakir MN; Shayan FK; Shirinkami N
    J Biochem Mol Toxicol; 2024 Aug; 38(8):e23782. PubMed ID: 39115384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of stimuli-responsive polymers as anticancer drug delivery systems.
    Taghizadeh B; Taranejoo S; Monemian SA; Salehi Moghaddam Z; Daliri K; Derakhshankhah H; Derakhshani Z
    Drug Deliv; 2015 Feb; 22(2):145-55. PubMed ID: 24547737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hypoxia and nanocarrier size on pH-responsive nano-delivery system to solid tumors.
    Soltani M; Souri M; Moradi Kashkooli F
    Sci Rep; 2021 Sep; 11(1):19350. PubMed ID: 34588504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Microenvironment Responsive RNA Drug Delivery Systems: Intelligent Platforms for Sophisticated Release.
    Wang G; Zhang M; Lai W; Gao Y; Liao S; Ning Q; Tang S
    Mol Pharm; 2024 Sep; 21(9):4217-4237. PubMed ID: 39056442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.
    Dai Y; Xu C; Sun X; Chen X
    Chem Soc Rev; 2017 Jun; 46(12):3830-3852. PubMed ID: 28516983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomedicine from amphiphilizedprodrugs: Concept and clinical translation.
    Xiang J; Liu X; Yuan G; Zhang R; Zhou Q; Xie T; Shen Y
    Adv Drug Deliv Rev; 2021 Dec; 179():114027. PubMed ID: 34732344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.